Jablum Coffee (Coffea arabica)

Jablum Coffee is a premium Jamaican Blue Mountain Coffea arabica cultivar containing approximately 1.2% caffeine by weight, which acts as an adenosine receptor antagonist to promote alertness and reduce perceived fatigue. Unlike robusta varieties, its lower chlorogenic acid bitterness and distinct bean morphology are prized for sensory quality rather than documented therapeutic applications.

Origin & History

Jablum Coffee is a premium cultivar variant of Coffea arabica grown in Jamaica's Blue Mountain region. This arabica variety is characterized by its larger bean size, distinctive S-shaped crease, and lower caffeine content (~1.2%) compared to robusta varieties (~2.2%).

Historical & Cultural Context

No traditional medicinal use or historical therapeutic applications documented in the provided research. Information limited to commercial cultivation practices and flavor characteristics.

Health Benefits

• No clinical health benefits documented - research focuses solely on agricultural characteristics
• Contains approximately 1.2% caffeine by weight (no therapeutic studies provided)
• Flavor profile described as superior to robusta (no health implications studied)
• Bean size and shape characteristics documented (no biomedical relevance established)
• Growing conditions and altitude preferences noted (no clinical significance demonstrated)

How It Works

Caffeine, the primary bioactive alkaloid in Jablum Coffee at roughly 1.2% dry weight, competitively blocks A1 and A2A adenosine receptors in the central nervous system, preventing adenosine-mediated inhibition of dopamine and norepinephrine signaling. This disinhibition elevates cyclic AMP via reduced phosphodiesterase activity and promotes catecholamine release, producing stimulant effects. Chlorogenic acids present in arabica varieties also transiently inhibit glucose-6-phosphatase and modulate GLP-1 secretion, though no specific studies on Jablum's chlorogenic acid profile have been published.

Scientific Research

No clinical trials, RCTs, or meta-analyses were found in the provided research. The available data consists entirely of botanical and agricultural descriptions without any PMIDs or medical literature citations.

Clinical Summary

No clinical trials have been conducted specifically on Jablum Coffee or the Jamaican Blue Mountain arabica cultivar; available research addresses its agricultural and organoleptic characteristics rather than human health outcomes. General Coffea arabica research suggests caffeine at doses of 3–6 mg/kg body weight improves cognitive performance, reaction time, and endurance exercise capacity in randomized controlled trials with sample sizes ranging from 20 to 200 participants. Chlorogenic acids from arabica coffee have shown modest fasting glucose reductions (approximately 5–10 mg/dL) in short-term trials, but these findings cannot be extrapolated to Jablum specifically without cultivar-level phytochemical data. The overall evidence for Jablum as a distinct therapeutic agent is absent; any attributed benefits derive from general arabica coffee literature.

Nutritional Profile

Jablum Coffee (Coffea arabica, Jamaica Blue Mountain cultivar) shares the general nutritional composition of high-grade arabica coffee beans. Raw green beans contain approximately 10-13% protein (including free amino acids such as glutamic acid, aspartic acid, and leucine), 15-18% total lipids (dominated by diterpenes cafestol and kahweol at approximately 0.2-0.8% of dry weight, linoleic acid comprising ~40% of fatty acid fraction), and 60-65% carbohydrates (primarily sucrose at 6-9% in green beans, largely degraded during roasting; polysaccharides including galactomannans and arabinogalactans at ~50% dry weight). Caffeine content is documented at approximately 1.2% by dry weight, consistent with arabica species range (0.9-1.4%), notably lower than robusta (~2.7%). Chlorogenic acids (primarily 5-caffeoylquinic acid) are present at 5.5-8% in green beans, reducing to 1.5-3% post-roasting due to thermal degradation. Trigonelline is present at approximately 0.6-1.2% (precursor to niacin/vitamin B3 upon roasting). Roasted brew (per 240ml serving) yields approximately 2-5mg niacin, trace potassium (~116mg), magnesium (~7mg), and manganese (~0.05mg). Bioavailability note: diterpenes cafestol and kahweol are largely retained in unfiltered preparations; paper filtration removes >90% of these compounds. Antioxidant capacity (DPPH assay) is consistent with high-altitude arabica beans, though no Jablum-specific ORAC or FRAP values have been independently published.

Preparation & Dosage

No clinically studied dosage ranges available in the provided research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients documented in research

Safety & Interactions

Caffeine from Jablum Coffee can cause tachycardia, anxiety, insomnia, and gastrointestinal upset at intakes above 400 mg/day in healthy adults, the upper limit recognized by the European Food Safety Authority. It inhibits CYP1A2 substrates and can potentiate sympathomimetic drugs including pseudoephedrine and certain SSRIs, while reducing the efficacy of adenosine-based medications such as regadenoson. Pregnant individuals should limit total caffeine intake to under 200 mg/day due to associations with reduced fetal birth weight at higher exposures. Those with cardiac arrhythmias, severe hypertension, anxiety disorders, or peptic ulcer disease should use caffeine-containing products cautiously and consult a physician.